New drug aims to make heart surgery safer
NCT ID NCT05881291
Summary
This study tested a new anesthetic drug called ciprofol during a minimally invasive heart valve replacement procedure. Researchers compared it to the standard drug propofol in 124 older patients to see if ciprofol causes fewer drops in blood pressure and other side effects. The goal was to find a safer option for keeping patients comfortably asleep during this delicate surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRANSCATHETER AORTIC VALVE REPLACEMENT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Second Affiliated Hospital of Zhejiang University anesthesiology department
Hangzhou, Zhejiang, 310000, China
Conditions
Explore the condition pages connected to this study.